Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7247222

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
94,035,000,000 JPY
93,934,000,000 JPY
71,955,000,000 JPY
72,044,000,000 JPY
72,886,000,000 JPY
72,984,000,000 JPY
75,946,000,000 JPY
76,034,000,000 JPY
73,929,000,000 JPY
74,979,000,000 JPY
Ordinary profit (loss)
21,279,000,000 JPY
22,766,000,000 JPY
10,220,000,000 JPY
9,951,000,000 JPY
8,930,000,000 JPY
8,727,000,000 JPY
17,866,000,000 JPY
17,542,000,000 JPY
18,178,000,000 JPY
18,222,000,000 JPY
Profit (loss) attributable to owners of parent
13,945,000,000 JPY
8,025,000,000 JPY
5,440,000,000 JPY
9,549,000,000 JPY
13,405,000,000 JPY
Comprehensive income
14,237,000,000 JPY
11,684,000,000 JPY
5,475,000,000 JPY
9,563,000,000 JPY
16,532,000,000 JPY
Net assets
152,634,000,000 JPY
153,484,000,000 JPY
143,755,000,000 JPY
143,319,000,000 JPY
136,563,000,000 JPY
136,836,000,000 JPY
138,325,000,000 JPY
136,590,000,000 JPY
136,257,000,000 JPY
134,954,000,000 JPY
Total assets
190,422,000,000 JPY
189,474,000,000 JPY
171,623,000,000 JPY
168,853,000,000 JPY
163,747,000,000 JPY
166,328,000,000 JPY
165,181,000,000 JPY
161,798,000,000 JPY
163,332,000,000 JPY
162,327,000,000 JPY
Net assets per share
3,974.47
3,996.60
3,796.05
3,784.55
3,644.33
3,636.17
3,642.34
3,611.75
3,555.93
3,521.92
Basic earnings (loss) per share
365.42
431.06
224.79
212.67
180.07
144.80
260.61
251.43
346.63
347.37
Diluted earnings per share
Equity-to-asset ratio
0.802 xbrli:pure
0.810 xbrli:pure
0.838 xbrli:pure
0.849 xbrli:pure
0.834 xbrli:pure
0.819 xbrli:pure
0.834 xbrli:pure
0.844 xbrli:pure
0.834 xbrli:pure
0.831 xbrli:pure
Rate of return on equity
0.094 xbrli:pure
0.111 xbrli:pure
0.061 xbrli:pure
0.057 xbrli:pure
0.050 xbrli:pure
0.040 xbrli:pure
0.073 xbrli:pure
0.070 xbrli:pure
0.101 xbrli:pure
0.101 xbrli:pure
Price-earnings ratio
12.3 xbrli:pure
10.4 xbrli:pure
15.4 xbrli:pure
16.3 xbrli:pure
20.5 xbrli:pure
25.5 xbrli:pure
14.9 xbrli:pure
15.5 xbrli:pure
12.5 xbrli:pure
12.5 xbrli:pure
Net cash provided by (used in) operating activities
29,780,000,000 JPY
2,577,000,000 JPY
9,253,000,000 JPY
13,336,000,000 JPY
14,380,000,000 JPY
Net cash provided by (used in) investing activities
-19,650,000,000 JPY
-5,854,000,000 JPY
-2,627,000,000 JPY
-7,888,000,000 JPY
-1,644,000,000 JPY
Net cash provided by (used in) financing activities
-5,369,000,000 JPY
-5,658,000,000 JPY
-6,990,000,000 JPY
-8,129,000,000 JPY
-8,752,000,000 JPY
Cash and cash equivalents
70,085,000,000 JPY
65,325,000,000 JPY
74,260,000,000 JPY
74,625,000,000 JPY
77,305,000,000 JPY
Number of employees
1 xbrli:pure
1,125 xbrli:pure
1 xbrli:pure
1,102 xbrli:pure
1,126 xbrli:pure
1,103 xbrli:pure
1,135 xbrli:pure
1,124 xbrli:pure
1,117 xbrli:pure
1,130 xbrli:pure
1,164 xbrli:pure
1,152 xbrli:pure
1,215 xbrli:pure
1,207 xbrli:pure
Average number of temporary employees
xbrli:pure
171 xbrli:pure
xbrli:pure
168 xbrli:pure
171 xbrli:pure
168 xbrli:pure
173 xbrli:pure
172 xbrli:pure
192 xbrli:pure
194 xbrli:pure
213 xbrli:pure
211 xbrli:pure
225 xbrli:pure
224 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.